Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
CASI Pharmaceuticals, Inc (DE) (CASI) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/18/2020 3 Xu Weihao (CFO) has filed a Form 3 on CASI Pharmaceuticals, Inc.
02/06/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
02/06/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
10/31/2018 3 Form 3 - Initial statement of beneficial ownership of securities:
10/02/2018 3 Chi George (CFO) has filed a Form 3 on CASI Pharmaceuticals, Inc.
10/02/2018 3 Zhang Larry (President, CASI China) has filed a Form 3 on CASI Pharmaceuticals, Inc.
04/05/2017 3 Zukiwski Alexander A (Chief Medical Officer) has filed a Form 3 on CASI Pharmaceuticals, Inc.
04/12/2013 3 Huang James (Director) has filed a Form 3 on ENTREMED INC
04/11/2013 3 Wu Alex (Director) has filed a Form 3 on ENTREMED INC
04/03/2012 3 Ren Ken Keyong (CEO) has filed a Form 3 on ENTREMED INC
01/12/2011 3 CAPITELLI SARA B (VP, Finance and PAO) has filed a Form 3 on ENTREMED INC
03/09/2009 3 Bray Mark R (Vice President, Research) has filed a Form 3 on ENTREMED INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy